Last reviewed · How we verify
Levo-bupivacaine 0.25
Levo-bupivacaine 0.25 is a Small molecule drug developed by Egymedicalpedia. It is currently in Phase 1 development.
At a glance
| Generic name | Levo-bupivacaine 0.25 |
|---|---|
| Sponsor | Egymedicalpedia |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Cervicothoracic Sympathetic Block Evaluation for Post COVID Condition (PHASE4)
- Role of Left Stellate Ganglion Block in Offering Myocardial Protection in On-pump Mitral Valve Replacement? A Histopathological and Clinical Assessment (NA)
- Erector Spınae Plane Block and Transmuscular Quadratus Lumborum Block In Kıdney Transplantatıon (NA)
- Lidocaine Versus Bupivacaine in Orthognathic Surgery (PHASE4)
- Comparison of Serratus Plane Block and Rhomboid Intercostal Plane Block for Postoperative Analgesia in Breast Reduction Surgery (NA)
- Single Shot Exparel vs Catheters in Lower Extremity Trauma (PHASE4)
- Effects of Erector Spinae Plane Block on Opioid Consumption, Anesthetic Consumption and Hemodynamics in Lumbar Disc Herniation Surgeries. (NA)
- COMPARISON OF BUPIVACAINE WITH AND WITHOUT DEXMEDETOMIDINE IN CAUDAL BLOCK AMONG CHILDREN UNDERGOING INGUINAL HERNIOTOMY (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Levo-bupivacaine 0.25 CI brief — competitive landscape report
- Levo-bupivacaine 0.25 updates RSS · CI watch RSS
- Egymedicalpedia portfolio CI
Frequently asked questions about Levo-bupivacaine 0.25
What is Levo-bupivacaine 0.25?
Levo-bupivacaine 0.25 is a Small molecule drug developed by Egymedicalpedia.
Who makes Levo-bupivacaine 0.25?
Levo-bupivacaine 0.25 is developed by Egymedicalpedia (see full Egymedicalpedia pipeline at /company/egymedicalpedia).
What development phase is Levo-bupivacaine 0.25 in?
Levo-bupivacaine 0.25 is in Phase 1.
Related
- Manufacturer: Egymedicalpedia — full pipeline
- Compare: Levo-bupivacaine 0.25 vs similar drugs
- Pricing: Levo-bupivacaine 0.25 cost, discount & access